Search for: "Janssen Research " Results 81 - 100 of 204
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
13 Apr 2017, 11:48 am by Scott
Janssen Research & Development, LLC., et. al., Case No. 2:17-cv03777 in the U.S. [read post]
5 Apr 2017, 1:00 am by Thorsten Bausch
Thus, “early certainty” is likely to be detrimental to innovation and furthering research, at least for several years to come. [read post]
2 Feb 2017, 7:42 am by Clay Hodges
Thousands of lawsuits have already been filed against Xarelto manufacturer Janssen Pharmaceuticals. [read post]
25 Jan 2017, 10:48 pm
  Birss J agreed with Floyd J in Actavis v Janssen [2008] EWHC 1422 (Pat) that the presence of another fairly remote possibility did not preclude a finding of “inevitable result”. [read post]
30 Dec 2016, 6:28 am by Law Offices of Jeffrey S. Glassman
  Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a wholly owned subsidiary of the pharmaceutical giant. [read post]
29 Dec 2016, 8:26 am by Clay Hodges
Despite large amounts of time and money spent on drug and medical device research and development, those drugs and devices don’t always work as intended. [read post]
18 Nov 2016, 12:44 am by John Collins
  The need to undertake further research would amount to an “undue burden” being placed on the skilled addressee. [read post]
11 Nov 2016, 10:29 am by Law Offices of Jeffrey S. Glassman
As it turns out, one type of machine used to monitor a patient’s blood was defective and was not providing researchers with accurate test results. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
Risperdal is the name Janssen patented and used when marketing the product. [read post]
16 Aug 2016, 11:32 am by Susan Kuehnhold
Meanwhile, dozens of Invokana lawsuits have been filed across the country against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, alleging that, in a rush to market a new medication, they failed to adequately research the potential risks and properly warn about the dangerous side effects. [read post]
30 Jul 2016, 8:09 pm by Jon Gelman
" He added, "National Jewish Health is conducting valuable research on respiratory disease critical for service members, veterans and civilians alike. [read post]
15 Jul 2016, 3:00 am by SOG Staff
  WRAL also reports that Wake County Assistant District Attorney Colleen Janssen resigned Friday. [read post]